SI-BONE preliminary Q4 revenue ~$48.8-49.0M (+26% YoY); turns adjusted EBITDA profitable

SI-BONE, Inc.

2024-FY EPS reported -$0.75 revenue$167,178,000

Q4 worldwide revenue ~$48.8-49.0M (+26% YoY); US revenue ~$46.7-46.9M (+28%).
Full year 2024 worldwide revenue ~$167.0-167.1M (+20%) and US revenue ~$158.2-158.4M (+21%).
Achieved adjusted EBITDA profitability in Q4 2024; cash & securities ~$150M at quarter end.
Active US physicians rose to ~1,390 (+23% YoY).
Results are preliminary and subject to adjustment; full earnings call expected late Feb 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.